share_log

Ancom Nylex's Net Profit Rises 8.4% YoY To RM81.5 Million For FY24

Ancom Nylex's Net Profit Rises 8.4% YoY To RM81.5 Million For FY24

安康納萊斯的淨利潤在FY24年同比增長8.4%至RM8150萬
Business Today ·  07/18 06:21

Ancom Nylex Berhad (Ancom Nylex), a leading fully integrated chemical group, recorded a rise in their profit after tax and non-controlling interest (net profit) figure of 8.4% year-on-year (YoY) to RM81.5 million for financial year ended 31 May 2024 (FY24).

領先的全球化學品綜合集團Ancom Nylex Berhad (Ancom Nylex)營業收入營收爲20億令吉,比一年前的20.4億令吉略有下降,但淨利潤(稅後淨利潤和非控制權益)同比大幅上升8.4%,達到8,150萬令吉,爲財政年度截至2024年5月31日(FY24)創下新高。

This surpassed the record RM75.1 million posted in FY23.

這超越了FY23所記錄的7,510萬令吉的紀錄。

For FY24, the Group's revenue came in at RM2 billion versus RM2.04 billion achieved a year ago.

在FY24期間,該集團的營收爲20億令吉,比一年前的20.4億令吉下降,而農業化學品部門則繼續成爲主要的增長貢獻者。

Meanwhile, Ancom Nylex posted its best-ever bottom-line performance for the financial year under review.

Ancom Nylex在審查期間的表現是有史以來最好的。

Its Agricultural Chemicals (Agrichem) segment continued to be the key growth contributor.

其農業化學品(Agrichem)部門繼續成爲主要的增長貢獻者。

Earnings before interest and tax (EBIT) for this segment jumped 25.3% YoY to RM106.5 million vis-à-vis RM85.0 million in FY23. This was chiefly attributed to stronger sales of products with better profit margins.

該部門的利息和稅前利潤(EBIT)同比大幅上漲25.3%至10650萬令吉,與FY23的8500萬令吉相比。這主要歸因於利潤更高的產品銷售更強勁。

Managing Director and Group CEO of Ancom Nylex, Lee Cheun Wei said, "While we anticipate market challenges to persist in the upcoming financial (FY25), Ancom Nylex continues to be upbeat on our growth prospects."

Ancom Nylex的董事長兼首席執行官李春偉表示:"儘管我們預計未來財政(YoY)的市場挑戰將持續存在,不過我們對Ancom Nylex的增長前景仍感到樂觀。"

"For our Agrichem segment, we are charting good progress for our new active ingredient (AI). While the production trial remains ongoing, we have successfully delivered samples to our clients for their in-house quality checks. We target to start commercial production of the new AI, mainly using the intermediate produced in-house to circumvent supply chain disruptions previously encountered when importing the intermediate inputs."

"對於我們的農業化學品部門,我們正在爲我們的新活性成分(AI)制定良好的計劃。雖然生產試驗仍在進行中,但我們已經爲我們的客戶成功提供了樣品,以供其進行內部質量檢查。我們的目標是開始商業化生產新的AI,主要使用公司內部生產的中間產品,以規避以往進口中間產品時遇到的供應鏈瓶頸。"

On the demand outlook, Latin and North American markets continue to experience sustained demand for our core AI-related products. The Group is making headway to expand their proprietary product offerings to larger-hectare crops in Latin America.

對於需求前景,拉丁美洲和北美市場持續體驗到我們核心AI相關產品的需求。我們正在努力將專有產品擴展到拉丁美洲更大的公頃作物。

"We are actively pursuing label registration and have completed three trials on larger-hectare crops with promising results. We have recently secured a long-term contract with a North American customer for the supply of a key AI product. This gives us healthy earnings visibility for the coming years," Lee added.

"我們正在積極尋求標籤註冊,並已在更大公頃的作物上完成三次試驗,結果非常有希望。我們最近與北美客戶簽訂了一項長期合同,爲關鍵的AI產品提供供應,這爲我們未來的盈利性提供了適度的可見性。"李春偉說道。

Lee explained that streamlining initiatives for their Industrial Chemicals segment have begun to bear fruit, with more benefits to performance expected to be realised in FY25.

李春偉解釋說,他們爲其工業化學品部門的簡化組織措施已經開始取得成果,預計在FY25將帶來更多的業績收益。

Forging ahead, we are looking to build on the strong positive momentum and record bottom-line performance achieved in FY24 while being mindful of the global economic conditions such as elevated shipping costs," Lee added.

李春偉補充說:"繼FY24實現了強勁的正向動量和記錄性的底線業績之後,我們將繼續前進,同時謹慎評估全球經濟狀況,例如高昂的物流成本。"

For the current quarter under review, the Group recorded a net profit of RM18.4 million against a revenue of RM487.0 million. This was a slight improvement from RM18.2 million and RM478.2 million respectively from a year ago.

在本季度審查期間,該集團的淨利潤爲1840萬令吉,營收爲48700萬令吉。這比一年前的1820萬和47820萬略有提高。

On a quarter on-quarter (QoQ) basis, 4QFY24 net profit was lower than the RM20.1 million achieved in the immediate preceding quarter due to higher impairment of trade receivables made in adherence to prudent accounting practices.

但與前一個季度相比,4QFY24的淨利潤低於當時取得的2010萬令吉,這是出於符合審慎會計實踐的應收貿易減值更高的原因。

Ancom Nylex generated yet another healthy net operating cash flow (NOCF) for FY24, amounting to RM128.6 million. The Group has been generating positive NOCF every year since FY18.

Ancom Nylex在FY24又創造了一個良好的淨經營現金流(NOCF),達到了12860萬令吉。從FY18以來,該集團每年都有創造正面NOCF。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論